期刊文献+

小鼠IL-4重组质粒的构建及目的蛋白的表达和纯化 被引量:2

The Construction of Recombinant Mouse Interleukin 4 Prokaryotic Expressing Plasmid and the Expression and Purification of Target Protein
在线阅读 下载PDF
导出
摘要 目的构建重组小鼠白细胞介素-4(rmIL-4)原核表达载体,在大肠杆菌BL21(DE3)中诱导表达,纯化目的蛋白并鉴定。方法将优化后的小鼠IL-4cDNA片段克隆到原核表达载体pET-32a(+)上,获得重组质粒pET32/rmIL-4,转入BL21(DE3)中经IPTG诱导表达得到包涵体。经复性处理后,依次用阴离子交换柱和分子筛纯化蛋白。对纯化得到的蛋白用Western blot检验免疫学特异性,用mIL-4生长依赖性细胞株CTLL-2增殖实验和动物实验测定其生物学活性。结果经酶切和测序证实重组质粒pET32/rmIL-4构建成功。诱导得到的包涵体用3mol/L盐酸胍溶液洗涤后溶于加有β-巯基乙醇的7mol/L盐酸胍溶液中变性,在pH9.5的条件下梯度透析复性。纯化出的蛋白经Western blot鉴定,能与抗小鼠IL-4抗体特异性结合;经细胞和动物实验鉴定,rmIL-4蛋白具有生物学活性,能刺激mIL-4生长依赖性细胞株CTLL-2增殖,使小鼠体内细胞因子发生从TH1到TH2的漂移。结论成功制备了高纯度、具有生物学活性的小鼠IL-4,为进一步研究其生物学功能提供了条件。 Objective To construct Recombinant Mouse Interleukin 4 prokaryotic expressing plasmid, express it in E. coli strain BL21 (DE3), purify and identify the expressed cytokine. Methods The optimized raiL- 4 cDNA fragment was cloned into the prokaryotie expressing vector pET-32a (+) to generate pET32/rmlL-4 and transformed into BL21 (DE3) cells. After induction, the expressed protein was found to be in the inclusion of E. coli cells. The induced product was purified through Q Sepharose Fast Flow Column and Gel Filtration Column under renaturing condition. The purified protein was identified by Western blot analysis, and the biologic activity was identified by the generation of raiL-4 dependence cell CTLL-2 and in vivo experiment of mouse psoriasis model. Results The recombinant plasmid pET32/rmlL-4 has been constructed correctly. The inclusion body was washed with 3 mol/L guanidine hydrochloride and denaturized in 7 mol/L guanidine hydrochloride. Then, the denaturized protein was gradient dialysis in the condition of pH 9. 5. The protein we purified has the right immunology specificity and biologic activity. Conclusion The recombinant mouse interleukin-4 with high purity and biologic activity was prepared in this study,which will become the basis for the further study of the biologic activity of IL-4.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2009年第4期579-583,共5页 Journal of Sichuan University(Medical Sciences)
基金 国家重点基础研究发展规划项目(2004cb518800)资助
关键词 重组小鼠白细胞介素-4蛋白纯化生物学活性 Recombinant mouse interleukin-4 Protein purification Biologic activit
  • 相关文献

参考文献14

  • 1Noma T.Function,molecular structure and gene expression of IL-4.Nippon Rinsho,1992;50(8):1787-1794.
  • 2Le HV,Ramanathan L,Labdon JE,et al.Isolation and characterization of multiple variants of recombinant human interleukin 4 expressed in mammalian cells.J Biol Chem,1988;263(22):10817-10823.
  • 3Jayaram B,Devos R,Guisez Y,et al.Purification of human interleukin-4 produced in Escherichia coli.Gene,1989;79(2):345-354.
  • 4F.M.奥斯伯,R.E.金斯顿,JG.赛德曼等著.严子颖,王海林译.编分子生物学指南.第1版.北京:科学出版社,1998:366-371.
  • 5Livak KJ,Schmittgen TD.Analysis of relative gene expression data using real-time quantitative PCR and the 2 (2Delta Delta C (T)) Method.Methods,2001;25(4):402-408.
  • 6Georgious G,Valax P.Expression of correctly folded protein in E.coli.Curr Opin Biotechnol,1996;7(2):190-197.
  • 7Kohno T,Carmichael DF,Sommer A,et al.Refolding of recobinant proteins.Curr Opin Biotechnol,1998;9(2):157-163.
  • 8罗惠霞,李敏,王玉炯.包涵体蛋白复性的几种方法[J].生物技术通报,2007,23(5):96-98. 被引量:25
  • 9麻晓庆,王继红,韩晓曦,褚丹,张丕桥,李庆伟.基因重组蛋白L243诱导表达包涵体的变性、复性与纯化[J].吉林医药学院学报,2007,28(1):1-3. 被引量:13
  • 10Davis LS,Lipsky PE,BottomLy K.Measurement of human and murine interleukin 2 and interleukin 4.Curr Protoc Immunol,2001; Chapter 6:Unit 6.3.

二级参考文献15

  • 1党双锁,王宏仓,贾晓黎,袁利超,王宝峰,张欣,张正国,程延安.幽门螺杆菌vacA基因重组表达的包涵体复性及ELISA方法的建立[J].世界华人消化杂志,2005,13(20):2500-2503. 被引量:9
  • 2KiethaberT, Rudolph R, Kohler H, et al.BioTechnologh, 1991,9 : 825 - 829.
  • 3Derman AI, Prinz W,Belin D,et al.Science, 1993,262:1744 - 1747.
  • 4Misawa S, Kunagai I.Biopolymer, 1999,51: 297 - 307.
  • 5White C B, Chen Q, Kenyon Gl, et al. J B io Chem, 1995,270:12990 - 12994.
  • 6Khan RH,Appa Rao KBC,Eshwari ANS,et al.Biotechnol Prog, 1998,14 : 722 - 728.
  • 7Lille H, Schwarz E, Rudolph R.Curr Opin Biotechnol, 1998,9(5 ): 497 - 501.
  • 8Rudolpg R, Lilie H.FASEBJ, 1996,10( 1 ) : 49 - 56.
  • 9Wetalaufer DB, Xie Y.Protein Sci, 1995,4(8 ) : 1535 - 1543.
  • 10Rozema D, Gellman SH.Biochemistry, 1996,35 ( 49 ) : 15760 - 15771.

共引文献33

同被引文献14

  • 1周世新,刘谨,徐永健,张珍祥.白介素4在Th细胞信号转导机制中的作用[J].国外医学(呼吸系统分册),2005,25(3):182-185. 被引量:6
  • 2邱燕,孙九如,黄阳滨,黄智华,陈霖杰,刘勇,林跃鑫.重组人IL-4大肠杆菌表达与纯化[J].生物工程学报,2006,22(6):962-967. 被引量:2
  • 3Howard M, Farrar J, Hilfiker M, et al. Identification of a T cell-de- rived b cell growth factor distinct from interleukin 2 [J]. J Exp Med, 1982, 155(3) : 914-923.
  • 4Noma T. Function, molecular structure and gene expression of IL-4 [ J]. Nihon Rinsho, 1992, 50(8) : 1787-1794.
  • 5Wu Z, MacPhee IA, Oliveira DB. Reactive oxygen species in the initi- ation of IL-4 driven autoimmunity as a potential therapeutic target [J].Curr Pharm Des, 2004, 10(8) : 899-913.
  • 6Lu X, Malumbres R, Shields B, et al. PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling [ J ]. Blood, 2008, 112 (10) : 4098-4108.
  • 7Harrington LE, Mangan PR, Weaver CT. Expanding the effector CD4 T-cell repertoire: the Thl7 lineage [J]. Curr Opin Immunol, 2006, 18(3) : 349-356.
  • 8Steinman L. A brief history of T(H) 17, the first major revision in the T( H ) 1/T(H) 2 hypothesis of T cell-mediated tissue damage [ J ]. Nat Med, 2007, 13(2) : 139-145.
  • 9Abraham C, Cho JH. Inflammatory bowel disease[J]. N Engl J Med, 2009, 361 (21): 2066-2078.
  • 10Hogaboam CM, Vallanee BA, Kumar A, et al. Therapeutic effects of in- terleukin-4 gene transfer in experimental inflammatory bowel disease [J].J Clin Invest, 1997, 100(11):2766-2776.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部